Registry of Lobbyists
| Corporation: | Boehringer Ingelheim Canada Ltd. |
| Associated registration: | 952146-371995-2 |
| Communication date: | 2023-04-24 |
| Posted date: | 2024-04-02 |
| Designated Public Office Holders who participated in the communication: |
Michelle Boudreau,
Executive Director, Office of Pharmaceutical Management Strategies
Health Canada (HC) Dr. Stephen Ellis, Member of Parliament House of Commons |
| Subject Matter of the communication: | Health |
| Responsible Officer who filed this communication report: | Mark Lewis |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |